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Background:
Heart failure (HF) is one of the most frequent cardiovascular diseases in the Western countries. Its prevalence 
in Europe varies from 0.4 to 2%. 
The aim of the study was to compare the performances of BNP (Biosite®) and NT-proBNP(Roche®) for 




? 47 men (mean age 76±25 years) and 51 women (mean age 65± 38 years)              from the University                
Hospital of Liège
? 43 non CRI including 35 non HF and 55 CRI including 23 non HF pts
BNP and NT-proBNP determinations were performed by an immunofluorescent assay (Biosite®) and by an 
electrochemiluminescence sandwich immunoassay (Roche Diagnostic ®), respectively.
Results and discussion:
In non CRI patients :
? mean BNP and NT-proBNP levels were 347 and 2375 pg/ml respectively
? the mean BNP/ NT-proBNP ratio was 8.65
In CRI patients :
?mean BNP and NT-proBNP levels were 1109 and 16374 pg/ml respectively 
?the mean BNP/ NT-proBNP ratio was 14.76 
We found a better correlation between the two peptides in the non CRI group (R2= 0, 93) (Fig.1) than in the 
CRI group (R2= 0, 86) (Fig.2). Using decise limits of 100pg/ml for BNP and 125 (<75 y) and 450 (> 75 y) pg/ml 
for NT-proBNP, the sensitivity for pointing out HF patients in the whole population was 92% for BNP and 98% 
for NT-proBNP. The negative predictive values (NPV) were 90 and 94% respectively. The specificity was 43% 
for BNP and 31% for NT-proBNP. The predictive positive values (PPV) were 49% and 52%, respectively.
Conclusion:
BNP and NT-proBNP level are correlated in CRI and non CRI pts, but in renal insufficiency, NT-proBNP levels 
increase to a greater extent than BNP. Both assays are useful to rule out CRI pts suspected of HF. However, in 
renal failure pts, higher decision limits should be used for improving the positive predictive value of the assays.
 Correla tion  NT-proBNP an d BNP in non  CRF patients  (n =43)
y  = 8 ,6478 x -  6 24,16
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 C orre la tion   B N P an d NT -proB NP in C R F pa tien ts  (n=5 5)
y =  18 ,002x  -  323 2,6
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